Literature DB >> 1617057

Neurological melioidosis: seven cases from the Northern Territory of Australia.

M L Woods1, B J Currie, D M Howard, A Tierney, A Watson, N M Anstey, J Philpott, V Asche, K Withnall.   

Abstract

Pseudomonas pseudomallei, which causes melioidosis, is most commonly associated with pulmonary infection. We describe seven patients who developed a neurological syndrome as the predominant manifestation of melioidosis: this syndrome was characterized by peripheral motor weakness (mimicking Guillain-Barré syndrome), brain-stem encephalitis, aseptic meningitis, and respiratory failure. Neurological melioidosis occurred in the absence of demonstrable foci of infection in the central nervous system (CNS) in five of six patients whose cerebrospinal fluid was available for culture. Computed tomography and magnetic resonance imaging of the brain and spinal cord of these patients were not suggestive of pyogenic infection, although the latter procedure detected brain-stem encephalitis. Autopsy findings in one case confirmed brain-stem encephalitis without evidence of direct bacterial infection. The clinical presentation of neurological melioidosis includes features of an exotoxin-induced neurological syndrome, with profound neurological disease occurring in the absence of apparent direct infection of the CNS. This syndrome appears to be a newly recognized clinical presentation of melioidosis.

Entities:  

Mesh:

Year:  1992        PMID: 1617057     DOI: 10.1093/clinids/15.1.163

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  16 in total

Review 1.  Rhombencephalitis / brainstem encephalitis.

Authors:  Burk Jubelt; Cornelia Mihai; Terrence M Li; Padma Veerapaneni
Journal:  Curr Neurol Neurosci Rep       Date:  2011-12       Impact factor: 5.081

2.  Arabinose assimilation defines a nonvirulent biotype of Burkholderia pseudomallei.

Authors:  M D Smith; B J Angus; V Wuthiekanun; N J White
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

Review 3.  Pathogens penetrating the central nervous system: infection pathways and the cellular and molecular mechanisms of invasion.

Authors:  Samantha J Dando; Alan Mackay-Sim; Robert Norton; Bart J Currie; James A St John; Jenny A K Ekberg; Michael Batzloff; Glen C Ulett; Ifor R Beacham
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

4.  Passive protection of diabetic rats with antisera specific for the polysaccharide portion of the lipopolysaccharide isolated from Pseudomonas pseudomallei.

Authors:  L E Bryan; S Wong; D E Woods; D A Dance; W Chaowagul
Journal:  Can J Infect Dis       Date:  1994-07

Review 5.  Melioidosis: epidemiology, pathophysiology, and management.

Authors:  Allen C Cheng; Bart J Currie
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

6.  Neurologic melioidosis.

Authors:  Martin Deuble; Chloe Aquilina; Robert Norton
Journal:  Am J Trop Med Hyg       Date:  2013-07-08       Impact factor: 2.345

7.  Evaluation of PCR for diagnosis of melioidosis.

Authors:  A Haase; M Brennan; S Barrett; Y Wood; S Huffam; D O'Brien; B Currie
Journal:  J Clin Microbiol       Date:  1998-04       Impact factor: 5.948

8.  The epidemiology and clinical spectrum of melioidosis: 540 cases from the 20 year Darwin prospective study.

Authors:  Bart J Currie; Linda Ward; Allen C Cheng
Journal:  PLoS Negl Trop Dis       Date:  2010-11-30

Review 9.  Cerebral melioidosis for the first time in the western hemisphere.

Authors:  Matthew L Vestal; Emily B Wong; Dan A Milner; William B Gormley; Ian F Dunn
Journal:  J Neurosurg       Date:  2013-06-14       Impact factor: 5.115

10.  Burkholderia pseudomallei Rapidly Infects the Brain Stem and Spinal Cord via the Trigeminal Nerve after Intranasal Inoculation.

Authors:  James A St John; Heidi Walkden; Lynn Nazareth; Kenneth W Beagley; Glen C Ulett; Michael R Batzloff; Ifor R Beacham; Jenny A K Ekberg
Journal:  Infect Immun       Date:  2016-08-19       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.